NVS vs VTAK
NVS (NVS) versus Catheter Precision Inc. (VTAK) — a side-by-side from cached financials, not a winner call.
NVS (NVS) common stock.
Catheter Precision Inc. (VTAK) is a medical devices company listed on US.
NVS does not have a complete income-statement cache yet.
Latest reported VTAK revenue for 2026-06-30 was $1.5M. Net income was -$5.0M. VTAK currently screens at market cap $3.0M.
NVS currently screens at market cap $0. VTAK currently screens at market cap $3.0M.
Not investment advice. Open the NVS and VTAK stock pages for the full models.
Not investment advice.